MDM2 and breast carcinoma: Meanwhile, TRIM31 inhibits MDM2-mediated K48 ubiquitination by competitively inhibiting the MDM2-p53 interaction, resulting in the stability and activation of p53, thus inhibiting the proliferation, migration, and invasion of breast cancer cells (Guo et al., 2021).